Master Alliance Provisions Guide (MAPGuide)

Funder Development Partnering Agreement

  • Protecting & sharing information | Publication of Results

4. Records and Standards

[…]

4.7 Clinical Trials Register. The Partner shall publish details of the Clinical Trial on a publicly accessible clinical trials register prior to the commencement of patient recruitment for a Clinical Trial, and shall provide to FUNDER evidence of such publication within twenty (20) Business Days of the same.

12. Announcements and Publications

[…]

12.2 Publications. The Partner shall ensure that the Project Lead furnishes FUNDER with a copy of any proposed publication or presentation which relates to a Project Invention or Foreground Intellectual Property at least fifteen (15) Business Days in advance of the submission of such proposed publication or presentation to a journal, editor or publication.

12.3 Patent publications. Following publication of any patent filed hereto, the Partner shall have the right to publish and reproduce any such publication freely with due acknowledgement of the sources including, where appropriate, sources of funding and the individuals and communities from whom data has been collected.

12.4. Open Access. A copy of the final manuscript of all research publications that relate to any Work Phase of the Project must be deposited into PubMed Central (or Europe PubMed Central) upon acceptance for publication, to be made freely available immediately after the journal publisher’s official date of final publication.

12.5. Open Data. The Partner shall publicly share all data and results (including negative results) arising from the FUNDER Funding as close to real time as possible. The Partner shall share its data through an easily discoverable public route (website or system) which includes a metadata description, where patient privacy is upheld and the system follows a request-for-information approach (where requests are fulfilled subject to an independent review and approval step). The Partner should share Clinical Trial results as close to real time as possible and at any rate within twelve (12) months of study completion.